AiM  Vol.9 No.11 , November 2019
The History of Tuberculosis: Past, Present, and Future
Abstract: Tuberculosis (TB), transmitted by the bacteria Mycobacterium tuberculosis has been a global epidemic for years. The evidence for infection with TB is centuries old. It can have an indolent course, and may remain inactive for years in individuals with the possibility of reactivation at any time, causing widespread systemic symptoms. The treatment and management of TB has become more effective over the years. It is estimated that more than one-third of the world population, especially in poor and developing countries are harboring this bacterium with varying manifestations of the disease from no symptoms to life-threatening infections. This manuscript describes the history of the disease and the discoveries. It also includes the recent advances and challenges facing the world and how governments and organizations are working together to control this disease.
Cite this paper: Prabhu, R. and Singh, V. (2019) The History of Tuberculosis: Past, Present, and Future. Advances in Microbiology, 9, 931-942. doi: 10.4236/aim.2019.911059.

[1]   Sulis, G., Roggi, A., Matteelli, A. and Raviglione, M. (2014) Tuberculosis: Epidemiology and Control. Mediterranean Journal of Hematology and Infectious Diseases, 6, e2014070.

[2]   World Health Organization (2018) Tuberculosis Key Facts 2018.

[3]   Zink, A., Sola, C., Reischl, U., Grabner, W., Rastogi, N., Wolf, H. and Nerlich, G. (2003) Characterization of Mycobacterium tuberculosis Complex DNAs from Egyptian Mummies by Spoligotyping. Journal of Clinical Microbiology, 41, 359-367.

[4]   Daniel, T.M. and Iverson, P.A. (2015) Hippocrates and Tuberculosis. The International Journal of Tuberculosis and Lung Disease, 19, 373-374.

[5]   Herzog, H. (1998) History of Tuberculosis. Respiration, 65, 5-15.

[6]   Moulis, G. (2012) Scrofula, the King’s Evil. Canadian Medical Association Journal, 184, 1061.

[7]   Sternbach, G. (1996) Percivall Pott: Tuberculosis Spondylitis. Journal of Emergency Medicine, 14, 79-83.

[8]   Doetsch, R. (1978) Benjamin Marten and His “New Theory of Consumptions.” Micriobiolical Reviews, 42, 521-528.

[9]   Keers, R.Y. (1978) Pulmonary Tuberculosis: A Journey Down the Centuries. Bailliere-Tindall, London.

[10]   Ferlinz, R. (1995) Die Tuberkulose in Deutschland und das deutsche Zentralkomitee zur Bekampfung der Tuberkulose. Pneumologie, 49, 617-632.

[11]   Loffler, W. (1958) Geschichte der Tuberkulose. In: Hein, J., Kleinschmidt, H. and Uehlinger, E., Eds., Handbuch der Tuberkulose, Stuttgart, Thieme.

[12]   Ayvazian, L.F. (1993) History of Tuberculosis. In: Reichman, L.B. and Hershfield, Eds., Tuberculosis, Dekker, New York.

[13]   Koch, R. (1901) The Fight against Tuberculosis in Light of the Experience Gained in the Successful Combat of Other Infectious Diseases. Boston Medical and Surgical Journal, 145, 109-115.

[14]   Sakula, A. (1979) Robert Koch (1843-1910): Founder of the Science of Bacteriology and Discoverer of the Tubercle Bacillus. British Journal of Diseases of the Chest, 73, 389-394.

[15]   Hardy Diagnostics. Lowenstein Jensen (LJ) Agar Instructions for Use.

[16]   UK Government. Housing of the Working Classes Act 1885.

[17]   Ferlinz, R. (1995) Die Tuberkulose in Deutschland und das deutsche Zentralkomitee zur Bekampfung der Tuberkulose. Pneumologie, 49, 617-632.

[18]   Pratt, J.H. (1944) The Evolution of Rest Treatment of Pulmonary Tuberculosis. The American Review of Tuberculosis, 50, 185-201.

[19]   Sigerist, H.E. (1961) A History of Medicine. Oxford University Press, London.

[20]   Bochalli, R. (1959) Die Entwicklung der Tuberkuloseforschung in der Zeit von 1878 bis 1959. Stuttgart, Thieme.

[21]   Luchino, F. (1982) BCG Vaccination. The American Review of Respiratory Disease, 125, 70-72.

[22]   Bryder, L. (2014) The Medical Research Council and Treatments for Tuberculosis before Streptomycin. Journal of the Royal Society of Medicine, 107, 409-415.

[23]   Sakula, A. (1983) Carlo Forlanini, Inventor of Artificial Pneumothorax for Treatment. Thorax, 38, 326-332.

[24]   Sakula, A. (1988) Selman Waksman (1888-1973), Discoverer of Streptomycin: A Centenary Review. British Journal of Diseases of the Chest, 82, 23-31.

[25]   Davies, P.D. (2000) Tuberculosis: The Global Epidemic. Journal of the Indian Medical Association, 98, 100-102.

[26]   Sandhu, G. (2011) Tuberculosis: Current Situation, Challenges, and Overview of Its Control Programs in India. Journal of Global Infectious Diseases, 3, 143-150.

[27]   Gupta, I. and Guin, P. (2010) Communicable Disease in the South-East Asia Region of the World Health Organization: Towards a More Effective Response. Bulletin of the World Health Organization, 88, 199-205.

[28]   Sandiford, P. (1999) WHOs DOTS Strategy. Directly Observed Therapy. The Lancet, 353, 755.

[29]   UNICEF India (2016) What We Do.

[30]   Americares (2016) What We Do.

[31]   Centers for Disease Control and Prevention (CDC) Tuberculosis.

[32]   Klopper, M., Warren, R.M., Hayes, C., Gey van Pittius, N.C., Streicher, E.M., Müller, B., Sirgel, F.A., Chabula-Nxiweni, M., Hoosain, E., Coetzee, G., van Helden, P.D., Victor, T.C. and Trollip, A.P. (2013) Emergence and Spread of Extensively and Totally Drug-Resistant Tuberculosis, South Africa. Emerging Infectious Diseases, 19, 449-455.

[33]   Lobue, P. (2006) Extensively Drug-Resistant Tuberculosis. Current Opinion in Infectious Diseases, 12, 1311-1318.

[34]   Pai, M., Kalantri, S., Aggarwal, A.N., Menzies, D. and Blumberg, H. (2006) Nosocomial Tuberculosis in India. Emerging Infectious Diseases, 12, 1311-1319.

[35]   Prasad, R., Gupta, N. and Singh, M. (2014) Multidrug Resistant Tuberculosis: Trends and Control. Indian Journal of Chest Diseases and Allied Sciences, 56, 237-246.

[36]   Agarwal, R. (2005) Treatment of Latent Tuberculosis Infection in India: Is It Worth the Salt? Lung India, 22, 105-106.

[37]   Aggarwal, A. (2009) Tuberculosis Transmission at Healthcare Facilities in India. Lung India, 26, 33-34.

[38]   Bying-Maddick, R. and Noursadeghi, M. (2016) Does Tuberculosis Threaten Our Ageing Populations? BMC Infectious Diseases, 16, 119.

[39]   World Health Organization (2014) Global Tuberculosis Report 2014.

[40]   McNerney, R. and Zumla, A. (2015) Impact of the Xpert MTB/RIF Diagnostic Test for Tuberculosis in Countries with a High Burden of Disease. Current Opinion in Pulmonary Medicine, 21, 304-308.

[41]   Al-Orainey, I. (2009) Diagnosis of Latent Tuberculosis: Can We Do Better? Annals of Thoracic Medicine, 4, 5-9.

[42]   WHO (2019) WHO End TB Strategy.